The selection of an enteral
formula must be patient specific. The functioning and capacity of the GI tract,
underlying disease states and patient tolerance must be assessed to determine
which formula should be selected. In terms of revenue, the Global Enteral Feeding
Formulas Market
was US$ 4680 Mn in 2020 and is estimated to be US$ h Mn by 2030. Nutritional support is considered as a vital
component in medical care. Enteral nutrition (EN) is provision of nutrients via
the gastrointestinal (GI) tract through a feeding tube, catheter or stoma. It
is the preferred route for the provision of nutrition for patients who cannot
meet their nutrition needs through voluntary oral intake. This type of feeding
provides many physiologic, metabolic, safety, and cost benefits over other
methods of feeding. Enteral nutrition is preferred as a route of administration
for nutritional support when gastrointestinal tract is functional. Compared to
the conventional central venous feeding, enteral feeding is associated with
fewer serious complications. It helps in better nutrient absorption and
facilitates better metabolic activities.
Top Players of Global Enteral Feeding Formulas
Market are Studied: NUTRICIA, Mead
Johnson & Company, LLC, Danone S.A., B. Braun Melsungen AG, Global Health
Products, Inc., Victus, Inc., Meiji Holdings Co., Ltd, Hormel Foods, LLC, Byram
Healthcare, Medline Industries Inc, Abbott Laboratories, Fresenius Kabi A,
Nutritional Medicinals, LLC, HOIL BIOMAED INC., Real Food Blends, Nestlé S.A.
amongst others
Click
to view the full report: https://www.absolutemarketsinsights.com/reports/Enteral-Feeding-Formulas-Market-2018-2026-44
Enteral
Feeding Formulas Market, by Stage
At present, the adult sub
segment is leading the market. Enteral nutrition in adults is prescribed when
an individual is not capable for oral intake of food. For instance, in
dysphagia or reduced level of consciousness, oral intake is not adequate to meet
nutritional requirements in adults. At that time, enteral nutrition has proved
to be safe, cost effective, and compatible with the body’s normal processes.
Enteral feeding formulas are used in adults suffering from various health
related conditions. They are used for patients suffering from severe acute
pancreatitis, high output proximal fistula, intractable vomiting or diarrhea
and others. Many a times due to major injuries, individuals get bedridden. Even
if an individual undergoes major surgeries of throat and stomach lining, he is
not allowed to consume food orally. At, such times eternal feeding formulas are
prescribed by doctors.
Enteral
Feeding Formulas Market, by Region
The region of North America
is on the forefront as compared to others during the forecast year 2021-2030,
owing to increasing number of citizens residing in the United States, suffering
from severe esophagus related conditions and widespread awareness about enteral
feeding devices. The American Cancer Society estimated that people suffering
from esophageal cancer in the United States for the year 2018 is 17,290. The
number has been increasing since 2010. The affected people are mostly advised
to opt for enteral feeding as their digestion system remains weak which
restricts them from taking anything orally.
·
To characterize, depict, section, and conjecture
the catchphrase market by type, application and locale
·
To analyze each submarket in terms of its own
growth trends, prospects and contribution to the overall market.
·
To provide detailed information about the major
factors influencing the growth of the market such as drivers, restraints,
opportunities, and challenges.
·
To profile the key market players, generate a
comparative analysis based on their business overviews, service offerings,
regional presence, business strategies and provide companies in-house
statistical tools required to understand the competitive landscape
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
No comments:
Post a Comment